Lonza Group

Valuation Analysis

About the Company

Lonza Group en bref

Lonza Group (LONN.SW) is currently trading at 562,20 CHF with a market capitalization of 34,0 Md €. The trailing P/E ratio stands at 36.22x, with a forward P/E of 25.6x. The 52-week range spans from 454,60 CHF to 591,00 CHF ; the current price is 4.9% below the yearly high. Year-over-year revenue growth stands at +11.2%.

💰 Dividende

Lonza Group pays an annual dividend of 5,00 CHF per share, representing a yield of 0.89%. The payout ratio stands at 32.28%.

📊 Avis des analystes

23 analystes évaluent Lonza Group (LONN.SW) au consensus : Acheter. L'objectif de cours moyen est de 680,70 CHF , soit un potentiel de +21.08% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 550,00 CHF à 835,00 CHF .

Lonza Group : la thèse d'investissement en détail

Lonza Group (LONN.SW) operates in the Healthcare — specifically Diagnostics & Research — and is headquartered in Switzerland. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Revenue is growing at a healthy 11.2% pace year-over-year, suggesting the business model continues to find new customers and pricing power. Earnings growth of 39.2% is outpacing revenue, a sign of operational leverage — fixed costs are being absorbed across a larger base. Wall Street consensus sits at Buy with an average price target implying roughly 21.08% upside from current levels — analyst sentiment is firmly constructive.

Le scénario baissier

Net margins remain negative, meaning every euro of revenue is still producing losses — the path to profitability is the central question for shareholders. Our valuation screen flags the stock as overvalued — current multiples imply the business needs to deliver well above its recent trajectory to justify the price.

Valorisation en contexte

The PEG ratio at 1.22 sits in the reasonable zone — the price tag is roughly aligned with the company's growth profile, neither punishing nor euphoric.

À surveiller

• The forward P/E of 25.6x is meaningfully below the trailing 36.22x — analysts expect earnings to step up; the next earnings release is the test.
• The analyst consensus price target implies 21.08% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Profil de risque

The data points to relatively defensive market behavior.

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Lonza Group?

Compare top-rated brokers — low fees, trusted providers, fully regulated.